Lean Body Mass and Side Effects in Patients With Lymphoma
The Relation Between Lean Body Mass and Side Effects Induced by Chemotherapy in Patients With Lymphoma: A Prospective Cohort Study
| Sponsors |
Lead Sponsor: Jens Rikardt Andersen |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Source | University of Copenhagen | ||||||||||
| Brief Summary | The primary purpose is to investigate the relationship between the dose of chemotherapeutic agents per kilogram of lean body mass (LBM) and the development of side effects induced by chemotherapy in patients with lymphoma. Secondarily, the maximum tolerable dose of chemotherapeutics (MTD), patients' quality of life (QOL), nutritional status and physical activity during the course of treatment are estimated. |
||||||||||
| Overall Status | Recruiting | ||||||||||
| Start Date | February 9, 2020 | ||||||||||
| Completion Date | March 3, 2021 | ||||||||||
| Primary Completion Date | January 31, 2021 | ||||||||||
| Study Type | Observational | ||||||||||
| Primary Outcome |
|
||||||||||
| Secondary Outcome |
|
||||||||||
| Enrollment | 141 | ||||||||||
| Condition | |||||||||||
| Eligibility |
Sampling Method: Probability Sample
Criteria:
Inclusion Criteria: - Patients receiving myelosuppressive treatment for malignant lymphoma assessed by the investigator. - Legal of age Exclusion Criteria: - ECOG Performance Status ≥2 - People who cannot speak and understand Danish - Pregnant and breastfeeding - Dementia Gender: All Minimum Age: 18 Years Maximum Age: N/A Healthy Volunteers: No |
||||||||||
| Overall Official |
|
||||||||||
| Overall Contact |
Last Name: Christian Bjørn Poulsen, MD, PhD Phone: +45 47324809 Email: [email protected] |
||||||||||
| Location |
|
||||||||||
| Location Countries |
Denmark |
||||||||||
| Verification Date |
January 2021 |
||||||||||
| Responsible Party |
Type: Sponsor-Investigator Investigator Affiliation: University of Copenhagen Investigator Full Name: Jens Rikardt Andersen Investigator Title: Sponsor - Investigator |
||||||||||
| Keywords | |||||||||||
| Has Expanded Access | No | ||||||||||
| Condition Browse | |||||||||||
| Arm Group |
Label: Malignant lymphoma patients Description: Identification of the patients who are/are not dose-reduced due to chemotherapy, and then look at the body composition in connection with this. |
||||||||||
| Patient Data | No | ||||||||||
| Study Design Info |
Observational Model: Cohort Time Perspective: Prospective |
||||||||||